M e d i c i n e A v e 2 GROUNDED IN DEPENDABILITY divalproex sodium 1. AGENCY: Wishbone/ITP CREATIVE TEAM: Mark McDowell, Stephanie Sorine CLIENT: Abbott 2. AGENCY: Flashpoint CREATIVE TEAM: Steve Frederick, Kerry Baker, Liz Blickle, Meaghan Golden CLIENT: Genentech 3. AGENCY: echo Torre Lazur CREATIVE TEAM: Steve Gourley, Melinda Milovic and Team CLIENT: sanofi-aventis www.BioOncology.com Translating science into life Our Vision extends beyond science making today’s therapies more accessible and tomorrow’s breakthroughs more achievable Sup orting today The Genentc lf9Ac es toCan; Foundation makes our marketed productsavailabletoqualifiedpatients inned* * Single Point of Contact (SPO») - As ists patients in obtainingreimbursement for Genentech products - Provides information about co-payas istance through Independent publiccharities Investingintomor ow * Genentech BloOncologyinvests de plyinresearchand development and is an industryleader in investinga percentage of an ual revenues back into REtl) * GenentechBioOncologyfunds grant and fel owship programs to sup ort medical education, partner withprofes ional societies, and encourage independent research otrd o» icrdcrrd uninsured due to po>tr dw at irjyr. theGtr*ptchAcvcv >Orer-undatki .o krum-.Ki f wiMtswfi)’. andmust •QualifiedjMlivuhwepotienHs*hum unir Tt hoet wrAkt a<lrK>urtnnoofre!l%>cy' f,t' o*jVuMr focfo<rr«u*ws ! pohfc u met fi uo\i/i *ndlncJlea!ctitewi 172
RkJQdWJsaXNoZXIy NDMwNDAx